These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 36099353)
1. [Antiphospholipid antibodies: what is new in 2022]. Melicine S; Gendron N; Darnige L; Mauge L Ann Biol Clin (Paris); 2022 Jul; 80(4):333-343. PubMed ID: 36099353 [TBL] [Abstract][Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria. Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA Front Immunol; 2018; 9():2971. PubMed ID: 30619328 [No Abstract] [Full Text] [Related]
4. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685 [TBL] [Abstract][Full Text] [Related]
5. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants. Ząbczyk M; Kopytek M; Natorska J; Undas A Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261 [TBL] [Abstract][Full Text] [Related]
6. Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome. Arachchillage DR; Efthymiou M; Mackie IJ; Lawrie AS; Machin SJ; Cohen H J Thromb Haemost; 2014 Nov; 12(11):1801-9. PubMed ID: 25196808 [TBL] [Abstract][Full Text] [Related]
8. Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study. Sciascia S; Radin M; Cecchi I; Rubini E; Scotta A; Rolla R; Montaruli B; Pergolini P; Mengozzi G; Muccini E; Baldovino S; Ferro M; Vaccarino A; Mahler M; Menegatti E; Roccatello D Front Immunol; 2019; 10():376. PubMed ID: 30891041 [No Abstract] [Full Text] [Related]
9. [Antiphospholipid antibodies: clinical significance and biological diagnosis]. Arnoux D; Boutière B; Sanmarco M Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099 [TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid Syndrome in Patients with Venous Thromboembolism. Pengo V; Denas G Semin Thromb Hemost; 2023 Nov; 49(8):833-839. PubMed ID: 35728601 [TBL] [Abstract][Full Text] [Related]
11. PREVALENCE OF ANTIPHOSPHOLIPID SYNDROME AMONG PREGNANT WOMEN IN LAUTECH TEACHING HOSPITAL OGBOMOSO NIGERIA. Taiwo O; Taofeek O; Samson O; Olanike O; Taiwo A West Afr J Med; 2023 Dec; 40(12 Suppl 1):S34-S35. PubMed ID: 38070133 [TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and potential treatment of antiphospholipid syndrome-related mainly on ischemic stroke]. Okuma H; Kitagawa Y Brain Nerve; 2013 Nov; 65(11):1319-32. PubMed ID: 24200610 [TBL] [Abstract][Full Text] [Related]
13. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome. Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262 [TBL] [Abstract][Full Text] [Related]
14. Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE. Elbagir S; Grosso G; Mohammed NA; Elshafie AI; Elagib EM; Zickert A; Manivel VA; Pertsinidou E; Nur MAM; Gunnarsson I; Rönnelid J; Svenungsson E Lupus; 2021 Jul; 30(8):1289-1299. PubMed ID: 33957795 [TBL] [Abstract][Full Text] [Related]
15. [Contribution of antiphosphatidylserine/prothrombin (anti-PS/PT) antibody detection in the diagnosis and management of antiphospholipid syndrome (APS)]. Delarue A; Dragon-Durey MA; Darnige L Rev Med Interne; 2022 Sep; 43(9):545-551. PubMed ID: 35752484 [TBL] [Abstract][Full Text] [Related]
16. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome]. Ieko M; Nakabayashi T; Tarumi T; Yoshida M; Naito S; Atsumi T; Koike T Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574 [TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies: evaluation of the thrombotic risk. Devreese KM Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657 [TBL] [Abstract][Full Text] [Related]
18. The antiphospholipid syndrome: still an enigma. Chaturvedi S; McCrae KR Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701 [TBL] [Abstract][Full Text] [Related]
19. [Venous thromboembolism and antiphospholipid syndrome - considerations on diagnosis and treatment]. van Mens TE; Middeldorp S; Coppens M Ned Tijdschr Geneeskd; 2023 Mar; 167():. PubMed ID: 36928879 [TBL] [Abstract][Full Text] [Related]
20. Antibody profiles for the diagnosis of antiphospholipid syndrome. Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]